Mirtazapin Ct Abz (Mirtazapine)

Mirtazapine, the active ingredient in Mirtazapin Ct Abz, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as an oral dosage form for oral use. It is prescribed for the treatment of major depressive disorder in adult patients, helping to improve mood, sleep and appetite.

GNH USA supplies Mirtazapin Ct Abz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution through established regulatory frameworks.

Mirtazapine is used in the treatment of depressive disorders by modulating noradrenergic and serotonergic pathways. - Major depressive disorder: reduces depressive symptoms and improves overall mood. - Depressive symptoms with insomnia: helps normalize sleep patterns and appetite. - Anxiety associated with depression: alleviates anxiety and tension in depressive episodes.

Mirtazapine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Sedation or drowsiness - Increased appetite and weight gain - Dry mouth - Constipation

Serious or Rare Side Effects: - Agranulocytosis or severe neutropenia - Hepatic dysfunction or jaundice - Serotonin syndrome when combined with other serotonergic agents

When prescribing mirtazapine, clinicians should consider several precautionary measures to ensure safe use. - Pregnancy: use only if potential benefit justifies potential risk; consult obstetric specialist. - Breastfeeding: assess infant exposure risk; monitor for sedation or weight changes. - Elderly patients: monitor for excessive sedation, orthostatic hypotension, and falls. - History of bipolar disorder: risk of switching to mania; observe mood changes closely. - Concomitant MAO inhibitors: avoid co‑administration and maintain recommended washout period. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture and light.

Mirtazapine can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis and serotonin syndrome. - Other serotonergic antidepressants (e.g., SSRIs, SNRIs, tricyclics): increase serotonin syndrome risk. - Potent CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise mirtazapine plasma levels.

Moderate Interactions (Monitor Closely): - CNS depressants (alcohol, benzodiazepines, antihistamines): enhanced sedation and respiratory depression. - Carbamazepine or phenytoin: may reduce mirtazapine concentrations, decreasing effectiveness. - Warfarin: possible alteration of INR; monitor coagulation parameters.